Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
NeCTuR
2 other identifiers
observational
750
1 country
1
Brief Summary
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2013
CompletedFirst Submitted
Initial submission to the registry
October 13, 2020
CompletedFirst Posted
Study publicly available on registry
January 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2044
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2044
March 5, 2026
March 1, 2026
30.6 years
October 13, 2020
March 3, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Disease characterization data
Information collected from retrospective and prospective review of medical records.
through study completion, an average of 1 year
Patient treatment data
Information collected from retrospective and prospective review of medical records.
through study completion, an average of 1 year
Patient outcome data
Information collected from retrospective and prospective review of medical records.
through study completion, an average of 1 year
Study Arms (1)
Observational (medical chart review)
Patients' medical records are reviewed retrospectively and prospectively. All prospective patients will be contacted via email, telephone, or U.S. Mail on case by case basis for up to 10 years to check status of disease and any further treatment received. Project staff can also access the patient's M. D. Anderson Epic medical record for updates. Request for additional clinic and treatment notes will be submitted to external medical institutions listed in the physician information form in order to access updated notes for non- M. D. Anderson patients.
Interventions
Receive follow up
Review of medical records
Eligibility Criteria
Patients with neuroendocrine cervical cancer
You may qualify if:
- Patients with a personal history of cervical cancer with any portion of neuroendocrine component (including mixed tumors) of the following histologic subtypes:
- Small cell neuroendocrine carcinoma
- Large cell neuroendocrine carcinoma
- Undifferentiated high-grade neuroendocrine carcinoma
- Patients may be in any stage of treatment, surveillance or recurrence at the time of initial participation in the study
- Patients with all stages of disease are considered eligible
- Patients who do not speak English can be eligible if accompanied by an institutional interpreter
- Patients who are receiving or have received treatment at any facility, including but not limited to M. D. Anderson Cancer Center are eligible
- Patient may be residents of any country and be of any ethnic background
- Patients who request to participate in the study, regardless of the method by which they learned of it, are eligible to participate, including, but not limited to patients who seek participation via the website
- Next of kin or legal authorized representatives of patients who are deceased but had a history of neuroendocrine carcinoma (NEC) of the cervix are eligible to participate
- Next of kin or legal authorized representatives of patients must read and speak English
You may not qualify if:
- Patients with other histologic subtypes of NEC of the cervix including typical and atypical carcinoid tumors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larissa A. Meyer
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2020
First Posted
January 25, 2021
Study Start
May 16, 2013
Primary Completion (Estimated)
January 1, 2044
Study Completion (Estimated)
January 1, 2044
Last Updated
March 5, 2026
Record last verified: 2026-03